We are testing a new treatment for patients with relapsed or refractory B-cell non-Hodgkin lymphoma. This study aims to find a safe dose and understand how the treatment works in humans.
Health conditions and diseases that the clinical trial is designed to study and treat.
Relapsed or refractory B-cell non-Hodgkin lymphomas are types of cancer that affect the lymphatic system, specifically B-cells. This condition occurs when the lymphoma returns after treatment (relapsed) or does not respond to treatment (refractory).
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.